The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: The results of a double blind, placebo controlled, multicenter clinical trial

Studies in the 1970s and 1980s reported that bacterial lysates (BL) had a prophylactic effect on recurrent respiratory tract infections (RRTI). However, controlled clinical study procedures have evolved substantially since then. We performed a trial using updated methods to evaluate the efficacy of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Immunol Lett
Autors principals: Braido, Fulvio, Melioli, Giovanni, Candoli, Piero, Cavalot, Andrea, Di Gioacchino, Mario, Ferrero, Vittorio, Incorvaia, Cristoforo, Mereu, Carlo, Ridolo, Erminia, Rolla, Giovanni, Rossi, Oliviero, Savi, Eleonora, Tubino, Libero, Reggiardo, Giorgio, Baiardini, Ilaria, di Marco, Eddi, Rinaldi, Gilberto, Canonica, Giorgio Walter, Accorsi, Carlo, Bossilino, Claudia, Bonzano, Laura, DiLizia, Michela, Fedrighini, Barbara, Garelli, Valentina, Gerace, Vincenzo, Maniscalco, Sara, Massaro, Ilaria, Messi, Alessandro, Milanese, Manlio, Peveri, Silvia, Penno, Arminio, Pizzimenti, Stefano, Pozzo, Tiziana, Raie, Alberto, Regina, Sergio, Sclifò, Francesca
Format: Artigo
Idioma:Inglês
Publicat: The Authors. Published by Elsevier B.V. 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7173099/
https://ncbi.nlm.nih.gov/pubmed/25445613
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.imlet.2014.10.026
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars